针灸推拿医学(英文版)
針灸推拿醫學(英文版)
침구추나의학(영문판)
Journal of Acupuncture and Tuina Science
2015年
6期
377-380
,共4页
推拿%按摩%颈椎病%椎间盘移位%颈痛%肌痛
推拿%按摩%頸椎病%椎間盤移位%頸痛%肌痛
추나%안마%경추병%추간반이위%경통%기통
Tuina%Massage%Cervical Spondylosis%Intervertebral Disc Displacement%Neck Pain%Myalgia
目的:观察压痛点强刺激推拿配合药物治疗颈椎间盘突出症的临床疗效。方法:将158例颈椎间盘突出症患者按就诊顺序随机分为观察组和对照组,每组79例。对照组口服美洛昔康片治疗,每次7.5 mg,每日1次。观察组在对照组基础上加用压痛点强刺激推拿治疗,每日1次。两组均连续治疗14 d后观察疗效。结果:观察组总有效率为92.4%,高于对照组的81.0%(P<0.05)。治疗后,两组疼痛视觉模拟量表(visual analogue scale, VAS)评分均较本组治疗前明显下降(均P<0.01),且观察组VAS评分明显低于对照组(P<0.01)。结论:压痛点强刺激推拿结合口服美洛昔康片治疗颈椎间盘突出症的疗效优于单纯口服美洛昔康片治疗,值得临床推广应用。
目的:觀察壓痛點彊刺激推拿配閤藥物治療頸椎間盤突齣癥的臨床療效。方法:將158例頸椎間盤突齣癥患者按就診順序隨機分為觀察組和對照組,每組79例。對照組口服美洛昔康片治療,每次7.5 mg,每日1次。觀察組在對照組基礎上加用壓痛點彊刺激推拿治療,每日1次。兩組均連續治療14 d後觀察療效。結果:觀察組總有效率為92.4%,高于對照組的81.0%(P<0.05)。治療後,兩組疼痛視覺模擬量錶(visual analogue scale, VAS)評分均較本組治療前明顯下降(均P<0.01),且觀察組VAS評分明顯低于對照組(P<0.01)。結論:壓痛點彊刺激推拿結閤口服美洛昔康片治療頸椎間盤突齣癥的療效優于單純口服美洛昔康片治療,值得臨床推廣應用。
목적:관찰압통점강자격추나배합약물치료경추간반돌출증적림상료효。방법:장158례경추간반돌출증환자안취진순서수궤분위관찰조화대조조,매조79례。대조조구복미락석강편치료,매차7.5 mg,매일1차。관찰조재대조조기출상가용압통점강자격추나치료,매일1차。량조균련속치료14 d후관찰료효。결과:관찰조총유효솔위92.4%,고우대조조적81.0%(P<0.05)。치료후,량조동통시각모의량표(visual analogue scale, VAS)평분균교본조치료전명현하강(균P<0.01),차관찰조VAS평분명현저우대조조(P<0.01)。결론:압통점강자격추나결합구복미락석강편치료경추간반돌출증적료효우우단순구복미락석강편치료,치득림상추엄응용。
Objective:To observe the clinical efficacy of tuina with intensive stimulation at tender points plus medication in treating cervical intervertebral disc herniation (CIDH). <br> Methods:Totally 158 CIDH patients were randomized into an observation group and a control group by their visit sequence, 79 cases in each group. The control group was intervened by oral administration of Meloxicam tablets, 7.5 mg for each dose, once each day. The observation group was additionally intervened by tuina with intensive stimulation at tender points based on the treatment given to the control group, once each day. The therapeutic efficacy was evaluated after successive 14-day treatment for the two groups. <br> Results:The total effective rate was 92.4% in the observation group, significantly higher than 81.0% in the control group (P<0.05). The visual analogue scale (VAS) scores dropped significantly after the treatment in both groups (bothP<0.01), and the VAS score of the observation group was significantly lower than that of the control group (P<0.01). <br> Conclusion:Tuina with intensive stimulation at tender points plus oral administration of Meloxicam tablets can produce a more significant efficacy in treating CIDH than taking Meloxicam alone, thus worth promoting in clinic.